Protéines recombinantes
Protéines modifiées ou manipulées codées par l'ADN recombinant et adaptées à divers usages, notamment la modification de séquences génétiques, la production massive de protéines et la fabrication de produits commerciaux.
À utiliser avec (application)
- (254)
- (4,067)
- (5)
- (2)
- (2)
- (3)
- (3)
- (4,318)
- (58)
- (1,081)
- (77)
- (155)
- (7)
- (6)
- (1)
- (1)
- (2)
- (6)
- (2)
- (172)
- (1,860)
Forme
- (28)
- (4,747)
Recombinant
- (4,768)
Statut réglementaire
- (45)
- (4,722)
Conjugué
- (4,766)
marques:
Gibco
Effacer toutes les sélections
Affichage les produits de la catégorie Protéines recombinantes.
Afficher tous les résultats de la recherche
Résultats de la recherche filtrée
Les produits de certains de nos fournisseurs ne s'affichent pas dans les résultats de la recherche filtrée. Veuillez
supprimer tous les filtres
pour voir ces produits.
Rechercher dans les résultats
Recherche par mot-clé:
Effacer la recherche
1
–
15
de
1,167
résultats
| Plage de pH | 7.4 |
|---|---|
| Poids moléculaire (g/mol) | 13.5 kDa |
| Forme de protéine | Recombinant, Ligand |
| Sous-type de protéine | Interleukins |
| Famille de protéines | Cytokines & Receptors |
| Statut réglementaire | RUO |
| Forme | Lyophilized |
| Contenu et stockage | -20°C |
| Nom usuel | IL-4 |
| À utiliser avec (application) | Bioactivity |
| Alias du gène | B cell growth factor 1; B_cell stimulatory factor 1; B-cell growth factor 1; B-cell IgG differentiation factor; B-cell stimulatory factor 1; BCGF1; BCGF-1; binetrakin; BSF1; BSF-1; cytokine; H-IL-4; IGG1 induction factor; IL2; IL4; Il-4; Il4e12; ILN; Interleukin; interleukin 4; interleukin 4 variant 2; interleukin 4 variant IL-4delta2; interleukin 4 variant IL-4delta3; interleukin 4 variant IL-4int2A; interleukin 4 variant IL-4int3A; interleukin 4 variant IL-4int3B; Interleukin4; interleukin-4; interleukin-4 precursor; lymphocyte stimulatory factor 1; MGC79402; M-IL-4; Pitrakinra |
| Conditions de stockage | -20°C |
| Système d’expression | E. coli |
| Méthode de purification | Purified |
| Formule | PBS with no preservative; pH 7.4 |
| Gamme de produit | Gibco |
| Recombinant | Recombinant |
| Shipping condition (Condition d'expédition) | Approved for shipment on Wet or Dry Ice |
| Numéro d'enregistrement | P07750 |
| Catégorie de recherche | Immunology, Stem Cell Research, Inflammation |
| Séquence | MHIHGCDKNH LREIIGILNE VTGEGTPCTE MDVPNVLTAT KNTTESELVC RASKVLRIFY LKHGKTPCLK KNSSVLMELQ RLFRAFRCLD SSISCTMNES KSTSLKDFLE SLKSIMQMDY S |
| Type de produit | Protein |
| Activité biologique | ED50 = 2 ng/mL; determined by the dose-dependent proliferation of mouse HT-2 cells. |
| Conjugué | Unconjugated |
| Espèces | Mouse |
| Nom | Mouse IL-4 |
| Symbole de gène | Il4 |
| Grade de qualité ou de pureté | >96% by SDS-PAGE and RP-HPLC |
| Activité | ED50 ≤ 2 ng/mL; determined by the dose-dependent proliferation of mouse HT-2 cells. |
| ID du gène (Entrez) | 16189 |
| Poids moléculaire (g/mol) | 17.4 kDa |
|---|---|
| Numéro d'enregistrement | P01375 |
| Séquence | VRSSSRTPSD KPVAHVVANP QAEGQLQWLN RRANALLANG VELRDNQLVV PSEGLYLIYS QVLFKGQGCP STHVLLTHTI SRIAVSYQTK VNLLSAIKSP CQRETPEGAE AKPWYEPIYL GGVFQLEKGD RLSAEINRPD YLDFAESGQV YFGIIAL |
| Concentration en endotoxines | <1 EU/μg |
| Activité biologique | The ED50 as determined by the cytolysis of murine L929 cells in the presence of Actinomycin D is ≤ 0.05 ng/ml, corresponding to a specific activity of ≥ 2 x 10^7 units/mg |
| Conjugué | Unconjugated |
| Sources | E. coli |
| Nom | Human TNF-alpha |
| Forme | Lyophilized |
| Contenu et stockage | -20°C |
| Symbole de gène | Tnf |
| Nom usuel | TNF alpha |
| À utiliser avec (application) | Control,Western Blot Control,ELISA Standard,Bioactivity |
| Alias du gène | APC1 protein; Cachectin; C-domain 1; C-domain 2; cTNF; DADB-70P7.1; DIF; ICD1; ICD2; Intracellular domain 1; Intracellular domain 2; N-terminal fragment; NTF; RATTNF; Tnf; TNF alpha; TNF superfamily; TNF α; TNF, macrophage-derived; TNF, monocyte-derived; TNFA; TNF-a; TNFalpha; TNF-alpha; Tnfsf1a; TNFSF2; TNFα; TNLG1F; Tumor necrosis factor; tumor necrosis factor (TNF superfamily, member 2); tumor necrosis factor alpha; tumor necrosis factor alpha (cachetin); tumor necrosis factor alpha precursor; tumor necrosis factor ligand 1F; tumor necrosis factor ligand superfamily member 2; Tumor necrosis factor, membrane form; Tumor necrosis factor, soluble form; tumor necrosis factor-alpha; tumor necrosis factor-alpha precursor; tumor-necrosis factor; tumour necrosis factor |
| Grade de qualité ou de pureté | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Système d’expression | E. coli |
| ID du gène (Entrez) | 7124 |
| Formule | Protein with no preservative |
| Recombinant | Recombinant |
| Poids moléculaire (g/mol) | 26.9 kDa |
|---|---|
| Numéro d'enregistrement | Q9BXY4 |
| Séquence | MHPNVSQGCQ GGCATCSDYN GCLSCKPRLF FALERIGMKQ IGVCLSSCPS GYYGTRYPDI NKCTKCKADC DTCFNKNFCT KCKSGFYLHL GKCLDNCPEG LEANNHTMEC VSIVHCEVSE WNPWSPCTKK GKTCGFKRGT ETRVREIIQH PSAKGNLCPP TNETRKCTVQ RKKCQKGERG KKGRERKRKK PNKGESKEAI PDSKSLESSK EIPEQRENKQ QQKKRKVQDK QKSVSVSTVH |
| Concentration en endotoxines | <1 EU/μg |
| Activité biologique | R-Spondin-3 enhances BMP-2-mediated differentiation of MC3T3-E1 cells. The expected ED50 for this effect is 0.8 -2.0 ug/ml |
| Conjugué | Unconjugated |
| Sources | CHO cells |
| Nom | Human R-Spondin-3 |
| Forme | Lyophilized |
| Contenu et stockage | -20°C |
| Symbole de gène | RSPO3 |
| Nom usuel | RSPO3 |
| À utiliser avec (application) | Control,Bioactivity |
| Alias du gène | 2810459H04Rik; AW742308; Cabriolet; cristin 1; Cristin1; cristin-1; cysteine-rich and single thrombospondin domain-containing protein 1; hPWTSR; hRspo3; Nucleopondin; protein with TSP type-1 repeat; PWTSR; RGD1563246; Roof plate-specific spondin-3; Rspo3; R-spondin 3; R-spondin 3 homolog; R-spondin 3 homolog (Xenopus laevis); R-spondin 3-like protein; R-spondin-3; Thrombospondin type-1 domain-containing protein 2; thrombospondin, type I, domain 2; thrombospondin, type I, domain containing 2; Thsd2; Unknown (protein for MGC:137973) |
| Grade de qualité ou de pureté | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
| Système d’expression | CHO cells |
| ID du gène (Entrez) | 84870 |
| Formule | Protein with no preservative |
| Recombinant | Recombinant |
| Poids moléculaire (g/mol) | 22.1 kDa |
|---|---|
| Numéro d'enregistrement | O95150 |
| Séquence | MQLRAQGEAS VQFQALKGQE FAPSHQQVYA PLRADGDKPR AHLTVVRQTP TQHFKNQFPA LHWEHELGLA FTKNRMNYTN KFLLIPESGD YFIYSQVTFR GMTSECSEIR QAGRPNKPDS ITVVITKVTD SYPEPTQLLM GTKSVCEVGS NWFQPIYLGA MFSLQEGDKL MVNVSDISLV DYTKEDKTFF GAFLL |
| Concentration en endotoxines | <0.1 EU/μg |
| Activité biologique | Determined by its ability to stimulate IFN-gamma production by human PBMC co-stimulated with Human IL-12 and Human IL-18. |
| Conjugué | Unconjugated |
| Sources | E. coli |
| Nom | Human TL-1A, Animal-Free |
| Forme | Lyophilized |
| Contenu et stockage | -20°C |
| Symbole de gène | TNFSF15 |
| Nom usuel | TL1A |
| À utiliser avec (application) | Control,Bioactivity |
| Alias du gène | bM20K13.3 (tumor necrosis factor (ligand) superfamily, member 15); MGC129934; MGC129935; TL1; TL1A; TNF ligand-related molecule 1; TNF superfamily ligand TL1A; TNFSF15; TNLG1B; tumor necrosis factor (ligand) superfamily member 15; tumor necrosis factor (ligand) superfamily, member 15; tumor necrosis factor ligand 1B; tumor necrosis factor ligand superfamily member 15; Tumor necrosis factor ligand superfamily member 15, membrane form; Tumor necrosis factor ligand superfamily member 15, secreted form; tumor necrosis factor superfamily member 15; vascular endothelial cell growth inhibitor; vascular endothelial growth inhibitor; vascular endothelial growth inhibitor-192A; Vegi; VEGI192A |
| Grade de qualité ou de pureté | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Système d’expression | E. coli |
| ID du gène (Entrez) | 9966 |
| Formule | Protein with no preservative |
| Recombinant | Recombinant |
| Poids moléculaire (g/mol) | 40.5 kDa |
|---|---|
| Numéro d'enregistrement | Q8TAD2 |
| Séquence | APRAGRRPAR PRGCADRPEE LLEQLYGRLA AGVLSAFHHT LQLGPREQAR NASCPAGGRP ADRRFRPPTN LRSVSPWAYR ISYDPARYPR YLPEAYCLCR GCLTGLFGEE DVRFRSAPVY MPTVVLRRTP ACAGGRSVYT EAYVTIPVGC TCVPEPEKDA DSINSSIDKQ GAKLLLGPND APAGP |
| Concentration en endotoxines | <0.1 EU/μg |
| Activité biologique | Measured by its binding ability in a functional ELISA. |
| Conjugué | Unconjugated |
| Sources | E. coli |
| Nom | Human IL-17D, Animal-Free |
| Forme | Lyophilized |
| Contenu et stockage | -20°C |
| Symbole de gène | IL17D |
| Nom usuel | IL17D |
| À utiliser avec (application) | Control,ELISA Standard,Binding Assay |
| Alias du gène | AI462269; FLJ30846; IL17D; IL-17D; IL-22; IL-27; Il27a; IL-3R; Interleukin; interleukin 17D; interleukin 27A; interleukin-17D; Interleukin-27; UNQ3096/PRO21175 |
| Grade de qualité ou de pureté | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Système d’expression | E. coli |
| ID du gène (Entrez) | 53342 |
| Formule | Protein with no preservative |
| Recombinant | Recombinant |
| Poids moléculaire (g/mol) | 18.9 kDa |
|---|---|
| Numéro d'enregistrement | P21781 |
| Séquence | CNDMTPEQMA TNVNCSSPER HTRSYDYMEG GDIRVRRLFC RTQWYLRIDK RGKVKGTQEM KNNYNIMEIR TVAVGIVAIK GVESEFYLAM NKEGKLYAKK ECNEDCNFKE LILENHYNTY ASAKWTHNGG EMFVALNQKG IPVRGKKTKK EQKTAHFLPM AIT |
| Type de produit | Protein |
| Concentration en endotoxines | <0.1 EU/μg |
| Activité biologique | Determined by a cell proliferation assay using 4 MBr-5 cells. The expected ED50 for this effect is 0.1-15 ng/ml |
| Conjugué | Unconjugated |
| Nom | Human FGF-7 (KGF), Animal-Free |
| Forme | Lyophilized |
| Contenu et stockage | -20°C |
| Symbole de gène | FGF7 |
| Nom usuel | KGF |
| À utiliser avec (application) | Control,Bioactivity |
| Alias du gène | Fgf7; FGF-7; Fibroblast growth factor 7; HBGF-7; Heparin-binding growth factor 7; keratinocyte growth factor; Kgf |
| Format | Lyophilized |
| Grade de qualité ou de pureté | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
| Activité | Determined by a cell proliferation assay using 4MBr-5 cells. The expected ED50 for this effect is 0.1-15 ng/ml. |
| Système d’expression | E. coli |
| Méthode de purification | Purified |
| ID du gène (Entrez) | 2252 |
| Formule | Protein with no preservative |
| Recombinant | Recombinant |
| Poids moléculaire (g/mol) | 19.3 kDa |
|---|---|
| Numéro d'enregistrement | O15520 |
| Séquence | MLGQDMVSPE ATNSSSSSFS SPSSAGRHVR SYNHLQGDVR WRKLFSFTKY FLKIEKNGKV SGTKKENCPY SILEITSVEI GVVAVKAINS NYYLAMNKKG KLYGSKEFNN DCKLKERIEE NGYNTYASFN WQHNGRQMYV ALNGKGAPRR GQKTRRKNTS AHFLPMVVHS |
| Type de produit | Protein |
| Concentration en endotoxines | <0.1 EU/μg |
| Activité biologique | Determined by the dose-dependent stimulation of thymidine uptake by BaF3 cells expressing FGF receptors. The expected ED50 is ≤ 0.5 ng/ml corresponding to a specific activity of ≥ 2 x 10^6 units/mg |
| Conjugué | Unconjugated |
| Nom | Human FGF-10, Animal-Free |
| Forme | Lyophilized |
| Contenu et stockage | -20°C |
| Symbole de gène | FGF10 |
| Nom usuel | FGF10 |
| À utiliser avec (application) | Control,Bioactivity |
| Alias du gène | AEY17; BB213776; FGF; Fgf10; FGF-10; Fibroblast growth factor; Fibroblast growth factor 10; Gsfaey17; Keratinocyte growth factor 2; produced by fibroblasts of urinary bladder lamina propria |
| Format | Lyophilized |
| Grade de qualité ou de pureté | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
| Activité | Determined by the dose-dependent stimulation of thymidine uptake by BaF3 cells expressing FGF receptors. The expected ED50 is ≤ 0.5 ng/ml corresponding to a specific activity of ≥ 2 x 10^6 units/mg. |
| Système d’expression | E. coli |
| Méthode de purification | Purified |
| ID du gène (Entrez) | 2255 |
| Formule | Protein with no preservative |
| Recombinant | Recombinant |
| Poids moléculaire (g/mol) | 17.4 kDa |
|---|---|
| Numéro d'enregistrement | P01375 |
| Séquence | VRSSSRTPSD KPVAHVVANP QAEGQLQWLN RRANALLANG VELRDNQLVV PSEGLYLIYS QVLFKGQGCP STHVLLTHTI SRIAVSYQTK VNLLSAIKSP CQRETPEGAE AKPWYEPIYL GGVFQLEKGD RLSAEINRPD YLDFAESGQV YFGIIAL |
| Concentration en endotoxines | <0.1 EU/μg |
| Activité biologique | The ED50 as determined by the cytolysis of murine L929 cells in the presence of Actinomyocin D is ≤ 0.05 ng/ml, corresponding to a specific activity of ≥ 2 x 10^7 units/mg |
| Conjugué | Unconjugated |
| Sources | E. coli |
| Nom | Human TNF-alpha, Animal-Free |
| Forme | Lyophilized |
| Contenu et stockage | -20°C |
| Symbole de gène | Tnf |
| Nom usuel | TNF alpha |
| À utiliser avec (application) | Control,Western Blot Control,ELISA Standard,Bioactivity |
| Alias du gène | APC1 protein; Cachectin; C-domain 1; C-domain 2; cTNF; DADB-70P7.1; DIF; ICD1; ICD2; Intracellular domain 1; Intracellular domain 2; N-terminal fragment; NTF; RATTNF; Tnf; TNF alpha; TNF superfamily; TNF α; TNF, macrophage-derived; TNF, monocyte-derived; TNFA; TNF-a; TNFalpha; TNF-alpha; Tnfsf1a; TNFSF2; TNFα; TNLG1F; Tumor necrosis factor; tumor necrosis factor (TNF superfamily, member 2); tumor necrosis factor alpha; tumor necrosis factor alpha (cachetin); tumor necrosis factor alpha precursor; tumor necrosis factor ligand 1F; tumor necrosis factor ligand superfamily member 2; Tumor necrosis factor, membrane form; Tumor necrosis factor, soluble form; tumor necrosis factor-alpha; tumor necrosis factor-alpha precursor; tumor-necrosis factor; tumour necrosis factor |
| Grade de qualité ou de pureté | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Système d’expression | E. coli |
| ID du gène (Entrez) | 7124 |
| Formule | Protein with no preservative |
| Recombinant | Recombinant |
| Poids moléculaire (g/mol) | 5.6 kDa |
|---|---|
| Numéro d'enregistrement | O14944 |
| Séquence | MVAQVSITKC SSDMNGYCLH GQCIYLVDMS QNYCRCEVGY TGVRCEHFFL |
| Concentration en endotoxines | <0.1 EU/μg |
| Activité biologique | Determined by its ability to stimulate the proliferation of mouse Balb/3T3 cells. The expected ED50 is = 0.2 ng/ml, corresponding to a specific activity of = 5 x 10^6 units/mg |
| Conjugué | Unconjugated |
| Sources | E. coli |
| Nom | Human Epiregulin, Animal-Free |
| Forme | Lyophilized |
| Contenu et stockage | -20°C |
| Symbole de gène | Ereg |
| Nom usuel | Epiregulin |
| À utiliser avec (application) | Control,Bioactivity |
| Alias du gène | Ep; Epiregulin; EPR; ER; EREG; Proepiregulin |
| Grade de qualité ou de pureté | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Système d’expression | E. coli |
| ID du gène (Entrez) | 2069 |
| Formule | Protein with no preservative |
| Recombinant | Recombinant |
| Poids moléculaire (g/mol) | 18.4 kDa |
|---|---|
| Numéro d'enregistrement | P21581 |
| Séquence | MQEICRNPVT DNVKDITKLV ANLPNDYMIT LNYVAGMDVL PSHCWLRDMV THLSVSLTTL LDKFSNISEG LSNYSIIDKL GKIVDDLVAC MEENAPKNVK ESLKKPETRN FTPEEFFSIF NRSIDAFKDF MVASDTSDCV LSSTLGPEKD SRVSVTKPFM LPPVA |
| Concentration en endotoxines | <0.1 EU/μg |
| Activité biologique | Determined by the dose-dependent stimulation of the proliferation of the human TF-1 cells. The expected ED50 for this effect is 20 - 40 ng/ml |
| Conjugué | Unconjugated |
| Sources | E. coli |
| Nom | Rat SCF, Animal-Free |
| Forme | Lyophilized |
| Contenu et stockage | -20°C |
| Symbole de gène | KITLG |
| Nom usuel | SCF |
| À utiliser avec (application) | Control,Bioactivity |
| Alias du gène | 710-712; blz; c-Kit ligand; Clo; cloud gray; Con; contrasted; CSF; DCUA; DFNA69; DKFZp686F2250; familial progressive hyperpigmentation 2; FPH2; FPHH; Gb; grizzle-belly; hematopoietic growth factor KL; H-SCF; Kit ligand; Kitl; Kitlg; kit-ligand; KL-1; Mast cell growth factor; MGF; M-SCF; Processed kit ligand; SCF; SF; SHEP7; sKITLG; Sl; SLF; Soluble KIT ligand; Steel factor; steel factor/kit ligand; stem cell factor; stem cell factor KL-1; stem cell factor, CSF |
| Grade de qualité ou de pureté | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Système d’expression | E. coli |
| ID du gène (Entrez) | 60427 |
| Formule | Protein with no preservative |
| Recombinant | Recombinant |
| Poids moléculaire (g/mol) | 8.5 kDa |
|---|---|
| Numéro d'enregistrement | P48061 |
| Séquence | KPVSLSYRCP CRFFESHVAR ANVKHLKILN TPNCALQIVA RLKNNNRQVC IDPKLKWIQE YLEKALNKRF KM |
| Concentration en endotoxines | <0.1 EU/μg |
| Activité biologique | Determined by its ability to chemoattract human peripheral T cells activated with PHA and IL-2 using a concentration range of 20.0-80.0 ng/ml |
| Conjugué | Unconjugated |
| Sources | E. coli |
| Nom | Human CXCL12 (SDF-1b), Animal-Free |
| Forme | Lyophilized |
| Contenu et stockage | -20°C |
| Symbole de gène | Cxcl12 |
| Nom usuel | CXCL12 beta |
| À utiliser avec (application) | Control,Bioactivity |
| Alias du gène | 12-O-tetradecanoylphorbol 13-acetate repressed protein 1; C Cmotif chemokine; C X C motif chemokine; CC motif chemokine; CCmotif chemokine; chemokine (C-X-C motif) ligand 12; chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1); CXC; CXC motif chemokine; C-X-C motif chemokine 12; C-X-C motif chemokine ligand 12; CXCL; CXCL12; Intercrine reduced in hepatomas; IRH; PBSF; pre-B cell growth-stimulating factor; pre-B-cell growth-stimulating factor; SCYB12; Sdf1; SDF-1; sdf-1 beta; SDF-1 gamma; SDF1A; SDF-1-alpha(3-67); SDF1B; SDF-1-beta(3-72); Stromal cell-derived factor 1; stromal cell-derived factor-1 gamma; thymic lymphoma cell-stimulating factor; TLSF; Tpar1 |
| Grade de qualité ou de pureté | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Système d’expression | E. coli |
| ID du gène (Entrez) | 6387 |
| Formule | Protein with no preservative |
| Recombinant | Recombinant |
| Poids moléculaire (g/mol) | 18 kDa |
|---|---|
| Numéro d'enregistrement | P01583 |
| Séquence | SAPFSFLSNV KYNFMRIIKY EFILNDALNQ SIIRANDQYL TAAALHNLDE AVKFDMGAYK SSKDDAKITV ILRISKTQLY VTAQDEDQPV LLKEMPEIPK TITGSETNLL FFWETHGTKN YFTSVAHPNL FIATKQDYWV CLAGGPPSIT DFQILENQA |
| Concentration en endotoxines | <0.1 EU/μg |
| Activité biologique | Determined by its ability to stimulate the proliferation of mouse D10S cells. The expected ED50 is ≤0.001 ng/ml, corresponding to a specific activity of ≥1 x 10^9 units/mg |
| Conjugué | Unconjugated |
| Sources | E. coli |
| Nom | Human IL-1 alpha, Animal-Free |
| Forme | Lyophilized |
| Contenu et stockage | -20°C |
| Symbole de gène | Il1a |
| Nom usuel | IL-1 alpha |
| À utiliser avec (application) | Control,Bioactivity |
| Alias du gène | CTLA8; hematopoietin-1; IL 1 a; IL 1α; IL1; IL-1 alpha; IL17; IL1A; Il-1a; IL-1alpha; IL1-ALPHA; IL1F1; IL1α; ILN; Interleukin; interleukin 1 alpha; interleukin 1, alpha; interleukin 17; interleukin 1a; interleukin 1-alpha; interleukin 1-alpha (AA 1 - 152); Interleukin1 alpha; interleukin-1 alpha; interleukin-1 alpha precursor; Interleukin-17A; preinterleukin 1 alpha; pre-interleukin-1 alpha; pro-interleukin-1-alpha; RP23-160G19.8 |
| Grade de qualité ou de pureté | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Système d’expression | E. coli |
| ID du gène (Entrez) | 3552 |
| Formule | Protein with no preservative |
| Recombinant | Recombinant |
| Poids moléculaire (g/mol) | 19 kDa |
|---|---|
| Numéro d'enregistrement | P09920 |
| Séquence | MVPLVTVSAL PPSLPLPRSF LLKSLEQVRK IQASGSVLLE QLCATYKLCH PEELVLLGHS LGIPKASLSG CSSQALQQTQ CLSQLHSGLC LYQGLLQALS GISPALAPTL DLLQLDVANF ATTIWQQMEN LGVAPTVQPT QSAMPAFTSA FQRRAGGVLA ISYLQGFLET ARLALHHLA |
| Concentration en endotoxines | <0.1 EU/μg |
| Activité biologique | Determined by its ability to stimulate the proliferation of mouse NFS-60 cells. The expected ED50 is ≤ 0.05 ng/ml, corresponding to a specific activity of ≥ 2 x 10^7 units/mg |
| Conjugué | Unconjugated |
| Sources | E. coli |
| Nom | Mouse G-CSF, Animal-Free |
| Forme | Lyophilized |
| Contenu et stockage | -20°C |
| Symbole de gène | Csf3 |
| Nom usuel | G-CSF |
| À utiliser avec (application) | Control,Bioactivity |
| Alias du gène | C17orf33; colony stimulating factor 3; colony stimulating factor 3 (granulocyte); CSF 3; CSF3; CSF3OS; Csfg; filgrastim; GCSF; G-CSF; Granulocyte colony-stimulating factor; granulocyte-colony stimulating factor; gsf3; lenograstim; MGC45931; MGI-IG; Pluripoietin; RP23-395E10.4 |
| Grade de qualité ou de pureté | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Système d’expression | E. coli |
| ID du gène (Entrez) | 12985 |
| Formule | Protein with no preservative |
| Recombinant | Recombinant |
